MUC1 and cancer: These findings indicate that TA-MUC1, particularly when aberrantly expressed in cancer, acts as a metabolic master regulator and exerts multiple effects on cholesterol and lipid metabolism, and thereby has the potential to act as an important pathogenic contributor to atherosclerosis.